Drug-eluting balloon tech attracts $16M round

Surgical balloons could become good drug-delivery tools. CV Ingenuity is developing a system that could bring a new twist to the treatment of peripheral artery disease, with a drug-eluting balloon system that delivers anti-clotting drugs during procedures to open narrowed blood vessels. With its novel treatment approach, the Palo Alto, CA-based firm has raised $16 million in a Series B round of financing led by new backer New Enterprise Associates. The round also attracted funding from previous investors BioStar Ventures, Synergy Ventures and Western Technology. Article

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.